These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 2568888)

  • 1. Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts.
    Kokai Y; Myers JN; Wada T; Brown VI; LeVea CM; Davis JG; Dobashi K; Greene MI
    Cell; 1989 Jul; 58(2):287-92. PubMed ID: 2568888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p185c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases.
    Quian XL; Decker SJ; Greene MI
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1330-4. PubMed ID: 1346931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-receptor antibodies reverse the phenotype of cells transformed by two interacting proto-oncogene encoded receptor proteins.
    Wada T; Myers JN; Kokai Y; Brown VI; Hamuro J; LeVea CM; Greene MI
    Oncogene; 1990 Apr; 5(4):489-95. PubMed ID: 1970151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation.
    Qian X; LeVea CM; Freeman JK; Dougall WC; Greene MI
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1500-4. PubMed ID: 7509075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinase-deficient neu proteins suppress epidermal growth factor receptor function and abolish cell transformation.
    Qian X; Dougall WC; Hellman ME; Greene MI
    Oncogene; 1994 May; 9(5):1507-14. PubMed ID: 7908733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
    Kokai Y; Dobashi K; Weiner DB; Myers JN; Nowell PC; Greene MI
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5389-93. PubMed ID: 2899889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand and p185c-neu density govern receptor interactions and tyrosine kinase activation.
    Samanta A; LeVea CM; Dougall WC; Qian X; Greene MI
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1711-5. PubMed ID: 7907421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation.
    Lehväslaiho H; Lehtola L; Sistonen L; Alitalo K
    EMBO J; 1989 Jan; 8(1):159-66. PubMed ID: 2565807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the neu/p185 and EGF receptor tyrosine kinases: implications for cellular transformation and tumor therapy.
    Dougall WC; Qian X; Greene MI
    J Cell Biochem; 1993 Sep; 53(1):61-73. PubMed ID: 7901229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
    Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K
    J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration by two-color flow cytometry that tyrosine kinase activity is required for down-modulation of the oncogenic neu receptor.
    Brown VI; Shah N; Smith R; Hellman M; Jarett L; Mikami Y; Cohen E; Qian X; Greene MI
    DNA Cell Biol; 1994 Feb; 13(2):193-209. PubMed ID: 7910024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function.
    Wada T; Qian XL; Greene MI
    Cell; 1990 Jun; 61(7):1339-47. PubMed ID: 1973074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.
    Menendez JA; Mehmi I; Verma VA; Teng PK; Lupu R
    Mol Carcinog; 2004 Nov; 41(3):164-78. PubMed ID: 15390078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-talk between the receptor tyrosine kinases Ron and epidermal growth factor receptor.
    Peace BE; Hill KJ; Degen SJ; Waltz SE
    Exp Cell Res; 2003 Oct; 289(2):317-25. PubMed ID: 14499632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structurally related class I and class II receptor protein tyrosine kinases are down-regulated by the same E3 protein coded for by human group C adenoviruses.
    Kuivinen E; Hoffman BL; Hoffman PA; Carlin CR
    J Cell Biol; 1993 Mar; 120(5):1271-9. PubMed ID: 8094718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2.
    Zhang K; Sun J; Liu N; Wen D; Chang D; Thomason A; Yoshinaga SK
    J Biol Chem; 1996 Feb; 271(7):3884-90. PubMed ID: 8632008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the neu oncogene product in cell transformation and normal development.
    Kokai Y; Wada T; Myers JN; Brown VI; Dobashi K; Cohen J; Hamuro J; Weiner DB; Greene MI
    Princess Takamatsu Symp; 1988; 19():45-57. PubMed ID: 2908355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of extracellular subdomains of p185c-neu and the epidermal growth factor receptor in ligand-independent association and transactivation.
    Kumagai T; Katsumata M; Hasegawa A; Furuuchi K; Funakoshi T; Kawase I; Greene MI
    Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9220-5. PubMed ID: 12867596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained mitogen-activated protein kinase activation is induced by transforming erbB receptor complexes.
    Wu CJ; Qian X; O'Rourke DM
    DNA Cell Biol; 1999 Oct; 18(10):731-41. PubMed ID: 10541432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the neu tyrosine kinase induces the fos/jun transcription factor complex, the glucose transporter and ornithine decarboxylase.
    Sistonen L; Hölttä E; Lehväslaiho H; Lehtola L; Alitalo K
    J Cell Biol; 1989 Nov; 109(5):1911-9. PubMed ID: 2572601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.